IFN-λ drives distinct lung immune landscape changes and antiviral responses in human metapneumovirus infection

J Sojati, OB Parks, Y Zhang, S Walters, J Lan… - Mbio, 2024 - Am Soc Microbiol
Human metapneumovirus (HMPV) is a primary cause of acute respiratory infection, yet there
are no approved vaccines or antiviral therapies for HMPV. Early host responses to HMPV …

[HTML][HTML] IFN-λ drives distinct lung immune landscape changes and antiviral responses in human metapneumovirus infection

J Sojati, OB Parks, Y Zhang, S Walters, J Lan… - mBio, 2024 - ncbi.nlm.nih.gov
Human metapneumovirus (HMPV) is a primary cause of acute respiratory infection, yet there
are no approved vaccines or antiviral therapies for HMPV. Early host responses to HMPV …

IFN-λ drives distinct lung immune landscape changes and antiviral responses in human metapneumovirus infection

J Sojati, OB Parks, Y Zhang, S Walters, J Lan… - mBio, 2024 - pubmed.ncbi.nlm.nih.gov
Human metapneumovirus (HMPV) is a primary cause of acute respiratory infection, yet there
are no approved vaccines or antiviral therapies for HMPV. Early host responses to HMPV …

IFN-λ drives distinct lung immune landscape changes and antiviral responses in human metapneumovirus infection.

J Sojati, OB Parks, Y Zhang, S Walters, J Lan… - Mbio, 2024 - europepmc.org
Human metapneumovirus (HMPV) is a primary cause of acute respiratory infection, yet there
are no approved vaccines or antiviral therapies for HMPV. Early host responses to HMPV …

IFN-λ drives distinct lung immune landscape changes and antiviral responses in human metapneumovirus infection.

J Sojati, OB Parks, Y Zhang, S Walters, J Lan… - Mbio, 2024 - europepmc.org
Human metapneumovirus (HMPV) is a primary cause of acute respiratory infection, yet there
are no approved vaccines or antiviral therapies for HMPV. Early host responses to HMPV …